One World Products Past Earnings Performance
Past criteria checks 0/6
One World Products has been growing earnings at an average annual rate of 15.8%, while the Pharmaceuticals industry saw earnings growing at 1.2% annually. Revenues have been declining at an average rate of 0.8% per year.
Key information
15.8%
Earnings growth rate
31.3%
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | -0.8% |
| Return on equity | n/a |
| Net Margin | -226,586.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How One World Products makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 0 | -6 | 2 | 0 |
| 30 Jun 24 | 0 | -6 | 2 | 0 |
| 31 Mar 24 | 0 | -5 | 2 | 0 |
| 31 Dec 23 | 0 | -4 | 2 | 0 |
| 30 Sep 23 | 0 | -2 | 2 | 0 |
| 30 Jun 23 | 0 | -3 | 2 | 0 |
| 31 Mar 23 | 0 | -3 | 2 | 0 |
| 31 Dec 22 | 0 | -3 | 2 | 0 |
| 30 Sep 22 | 0 | -4 | 3 | 0 |
| 30 Jun 22 | 0 | -3 | 3 | 0 |
| 31 Mar 22 | 0 | -3 | 3 | 0 |
| 31 Dec 21 | 0 | -4 | 3 | 0 |
| 30 Sep 21 | 0 | -5 | 3 | 0 |
| 30 Jun 21 | 0 | -6 | 4 | 0 |
| 31 Mar 21 | 0 | -9 | 8 | 0 |
| 31 Dec 20 | 0 | -10 | 8 | 0 |
| 30 Sep 20 | 0 | -8 | 8 | 0 |
| 30 Jun 20 | 0 | -9 | 9 | 0 |
| 31 Mar 20 | 0 | -6 | 6 | 0 |
| 31 Dec 19 | 0 | -6 | 6 | 0 |
| 30 Sep 19 | 0 | -6 | 6 | 0 |
| 31 Dec 18 | 0 | -3 | 2 | 0 |
Quality Earnings: OWPC is currently unprofitable.
Growing Profit Margin: OWPC is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OWPC is unprofitable, but has reduced losses over the past 5 years at a rate of 15.8% per year.
Accelerating Growth: Unable to compare OWPC's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OWPC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (54.6%).
Return on Equity
High ROE: OWPC's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.